Clinical Trials for Progressive Lymphoma Post Anti-CD19 CAR-T Cell Therapy

Find clinical trials for progressive lymphoma post anti-cd19 car-t cell therapy. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Testing Zanubrutinib and Tislelizumab as Well as Standard of Care for the Treatment of Patients With Progressive Lymphoma Post Anti-CD19 CAR-T Cell Therapy

NCT ID: NCT06919705

This clinical trial is exploring the effectiveness of two new drugs, zanubrutinib and tislelizumab, either alone or combined with standard treatment, for patients with lymphoma that has worsened af...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Toronto, Ontario, Canada

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions